By Matt Grossman

Johnson & Johnson on Thursday raised its revenue and earnings guidance for 2020 compared with forecasts it had issued in April.

The global health-products giant now expects adjusted earnings per share of $7.75 to $7.95 for the year, compared with the earlier forecast of $7.50 to $7.90. Analysts polled by FactSet were anticipating adjusted earnings per share of $7.75.

J&J now expects 2020 revenue of $79.9 billion to $81.4 billion, up from the prior guidance range of $77.5 billion to $80.5 billion. Analysts had forecast revenue of $79.77 billion.

The company says the new guidance includes the estimated impact of the coronavirus pandemic.

Write to Matt Grossman at matt.grossman@wsj.com

(END) Dow Jones Newswires

July 16, 2020 07:16 ET (11:16 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024 Plus de graphiques de la Bourse Johnson and Johnson
Johnson and Johnson (NYSE:JNJ)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024 Plus de graphiques de la Bourse Johnson and Johnson